Websites, domains, hosts that links to takedamedconnect.com

Find DEXILANT (dexlansoprazole) dosing information, clinical data, safety data, and Instant Savings Card information. See Important Safety Information and Prescribing Information.

Find TRINTELLIX (vortioxetine) dosing information, clinical study results, safety data, clinical pharmacology and savings information. See Important Safety Information and Prescribing Information.

Takeda MedConnect, operated by Takeda Medical Affairs, provides clinical information and resources about Takeda products to U.S. healthcare professionals.

Home | Information for healthcare professionals about Entyvio (vedolizumab), including indications, efficacy, and safety.

TRINTELLIX (vortioxetine) is indicated for the treatment of major depressive disorder in adults. WARNING: SUICIDAL THOUGHTS AND BEHAVIORS. Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24; there was a trend toward reduced risk with antidepressant use in patients aged 65 and older. In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber. TRINTELLIX has not been evaluated for use in pediatric patients.

TRINTELLIX (vortioxetine) is indicated for the treatment of major depressive disorder in adults. WARNING: SUICIDAL THOUGHTS AND BEHAVIORS. Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24; there was a trend toward reduced risk with antidepressant use in patients aged 65 and older. In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber. TRINTELLIX has not been evaluated for use in pediatric patients.